• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Asthma and COVID-19: Preconceptions about Predisposition.

作者信息

Beasley Richard, Hills Thomas, Kearns Nethmi

机构信息

Medical Research Institute of New Zealand Wellington, New Zealand and.

Department of Clinical Immunology Auckland District Health Board Auckland, New Zealand.

出版信息

Am J Respir Crit Care Med. 2021 Apr 1;203(7):799-801. doi: 10.1164/rccm.202102-0266ED.

DOI:10.1164/rccm.202102-0266ED
PMID:33600744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8017587/
Abstract
摘要

相似文献

1
Asthma and COVID-19: Preconceptions about Predisposition.哮喘与2019冠状病毒病：关于易感性的先入之见
Am J Respir Crit Care Med. 2021 Apr 1;203(7):799-801. doi: 10.1164/rccm.202102-0266ED.
2
Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.为何 COVID-19 患者的哮喘发病率较低，这证明了将 EDTA 溶液重新用于预防和治疗 COVID-19 疾病是合理的。
Med Hypotheses. 2020 Nov;144:110027. doi: 10.1016/j.mehy.2020.110027. Epub 2020 Jun 26.
3
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
4
Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu.大邱成人新冠肺炎住院患者中哮喘的特征及SARS-CoV-2清除延迟的危险因素
Allergy. 2021 Mar;76(3):918-921. doi: 10.1111/all.14609. Epub 2020 Oct 18.
5
The Impact of Asthma on Mortality in Patients With COVID-19.哮喘对COVID-19患者死亡率的影响。
Chest. 2020 Dec;158(6):2290-2291. doi: 10.1016/j.chest.2020.05.575. Epub 2020 Jun 6.
6
Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study.因严重急性呼吸综合征冠状病毒2型肺炎住院的哮喘患者的临床病程及结局：一项单中心回顾性研究。
Ann Allergy Asthma Immunol. 2020 Dec;125(6):707-709. doi: 10.1016/j.anai.2020.07.029. Epub 2020 Aug 1.
7
Genetic variation of allergic disease is associated with the susceptibility to COVID-19.过敏性疾病的基因变异与对新冠病毒的易感性有关。
J Infect. 2022 May;84(5):e92-e93. doi: 10.1016/j.jinf.2022.01.015. Epub 2022 Jan 14.
8
[COVID-19 and asthma control].[新型冠状病毒肺炎与哮喘控制]
Rev Mal Respir. 2021 Jan;38(1):111-113. doi: 10.1016/j.rmr.2020.11.006. Epub 2020 Nov 17.
9
Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19.过敏性疾病的遗传易感性与新冠病毒疾病的风险呈负相关。
Allergy. 2021 Jun;76(6):1911-1913. doi: 10.1111/all.14728. Epub 2021 Jan 12.
10
Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.西班牙马德里新冠肺炎住院患者中合并2型疾病的哮喘患者的患病率、特征及结局
J Investig Allergol Clin Immunol. 2020;30(5):382-384. doi: 10.18176/jiaci.0627. Epub 2020 Jun 18.

引用本文的文献

1
The acute care burden of asthma in children was profoundly reduced during the COVID-19 pandemic: A multi-centre Canadian retrospective study.在新冠疫情期间，儿童哮喘的急性护理负担大幅减轻：一项加拿大多中心回顾性研究。
Paediatr Child Health. 2023 Jun 26;29(2):98-103. doi: 10.1093/pch/pxad037. eCollection 2024 May.
2
D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir.D,L-赖氨酸乙酰水杨酸酯+甘氨酸（LASAG）可降低 SARS-CoV-2 复制，并与瑞德西韦具有相加作用。
Int J Mol Sci. 2022 Jun 21;23(13):6880. doi: 10.3390/ijms23136880.
3
The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium.2 型哮喘介质白细胞介素 13 抑制支气管上皮严重急性呼吸综合征冠状病毒 2 的感染。
Am J Respir Cell Mol Biol. 2022 Apr;66(4):391-401. doi: 10.1165/rcmb.2021-0364OC.
4
Charting a course for the management of long COVID.为长期新冠的管理制定路线。
Lancet Respir Med. 2021 Dec;9(12):1358-1360. doi: 10.1016/S2213-2600(21)00314-3. Epub 2021 Aug 17.
5
The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium.2型哮喘介质白细胞介素-13抑制支气管上皮细胞的新型冠状病毒感染。
bioRxiv. 2021 Feb 25:2021.02.25.432762. doi: 10.1101/2021.02.25.432762.

本文引用的文献

1
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease.成人 COVID-19 患者中的哮喘。患病率和严重疾病风险。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):893-905. doi: 10.1164/rccm.202008-3266OC.
2
Reduced mortality in New Zealand during the COVID-19 pandemic.新冠疫情期间新西兰死亡率降低。
Lancet. 2021 Jan 2;397(10268):25. doi: 10.1016/S0140-6736(20)32647-7. Epub 2020 Dec 14.
3
Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis.COVID-19 合并哮喘及相关结局的患病率：系统评价和荟萃分析。
J Allergy Clin Immunol Pract. 2021 Feb;9(2):693-701. doi: 10.1016/j.jaip.2020.11.054. Epub 2020 Dec 9.
4
Influenza control during the COVID-19 pandemic.2019冠状病毒病大流行期间的流感防控
Lancet. 2020 Nov 21;396(10263):1633-1634. doi: 10.1016/S0140-6736(20)32166-8. Epub 2020 Oct 22.
5
Why asthma might surprisingly protect against poor outcomes in COVID-19.为什么哮喘可能出人意料地保护 COVID-19 患者免受不良结局影响。
Eur Respir J. 2020 Dec 10;56(6). doi: 10.1183/13993003.03045-2020. Print 2020 Dec.
6
Asthma-associated risk for COVID-19 development.哮喘与 COVID-19 发展的相关性风险。
J Allergy Clin Immunol. 2020 Dec;146(6):1295-1301. doi: 10.1016/j.jaci.2020.09.017. Epub 2020 Sep 28.
7
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.过敏疾病与 COVID-19 的易感性和严重程度：一项全国性队列研究。
J Allergy Clin Immunol. 2020 Oct;146(4):790-798. doi: 10.1016/j.jaci.2020.08.008. Epub 2020 Aug 15.
8
Successful Elimination of Covid-19 Transmission in New Zealand.新西兰成功消除新冠病毒传播
N Engl J Med. 2020 Aug 20;383(8):e56. doi: 10.1056/NEJMc2025203. Epub 2020 Aug 7.
9
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.需要住院的 COVID-19 肺炎合并哮喘患者的特征和结局。
Eur Respir J. 2020 Nov 5;56(5). doi: 10.1183/13993003.01875-2020. Print 2020 Nov.
10
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.英国生物库社区队列中预测 COVID-19 和死亡率的预先存在的合并症。
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230. doi: 10.1093/gerona/glaa183.